首页> 外文期刊>European Journal of Medicinal Plants >In vivo Antiplasmodial Activity of the StemExtracts of Balanites aegyptiaca (L) Delile
【24h】

In vivo Antiplasmodial Activity of the StemExtracts of Balanites aegyptiaca (L) Delile

机译:Balanites aegyptiaca(L)Delile干提取物的体内抗血浆活性。

获取原文
       

摘要

Aims: To investigate in vivo antiplasmodial activity of the stem extracts of Balanites aegyptiaca (L) Del.Study Design: Animal model infected with Plasmodium berghei.Place and Duration of Study: Department of Biochemistry, Federal University of Technology, Minna, Niger State, Nigeria, between March 2011 and May 2011.Methodology: Twenty healthy Swiss albino mice of either sex weighing between 20-30g were selected and divided into five groups. One group served as control, another group as standard and the others as the test groups for hexane, ethylacetate and methanolic extracts respectively. The mice were infected with Chloroquine sensitive strain of Plasmodium berghei and left for 72hours for the infection to be established. 600 mgkg-1 bw day-1 dose was determined as safe and used for the analysis. After 72 hours of infection, the plant extracts were administered subcutaneously once daily for 4 days from D3 to D7. The control group was given 0.9w/v of normal saline. Thick and thin blood smears from the tail blood were examined for parasites. 5mg/kg bw of Chloroquine phosphate, used as control drug, was administered to the positive control. Results: None of the three fractions (Hexane, Ethylacetate and Methanolic extracts) of B. aegyptiaca was completely able to clear the parasites in circulation. In fact, the group of mice given methanolic extract of B. aegyptiaca died before the control group while both groups given ethylacetate and Hexane fractions died on the 14th day after infection. The mice administered with hexane and ethyl acetate extracts suppressed parasitaemia on the 6th and 10th day respectively, these suggest that purification and isolation of these crude extracts to know the active compound responsible for the decrease in parasitaemia can be use as drug target in the treatment of malaria,Conclusion: Stem extracts of B. aegyptiaca have suppressive effect on Plasmodium parasites but no curative effect. Further purification and isolation active compounds can help in discovery of a new antimalaria drug. It could thus be assumed that B. aegyptiaca is useful in the herbal malarial management by other mechanism other than plasmodicidal effect .Histological studies could establish reason(s) for the death of group treated with methanolic extract before the control group.
机译:目的:研究Balanites aegyptiaca(L)Del茎提取物的体内抗疟原虫活性研究设计:感染伯氏疟原虫的动物模型研究地点和持续时间:尼日尔州明那市联邦科技大学生物化学系尼日利亚,2011年3月至2011年5月。方法:选择20只体重在20至30g之间的健康瑞士白化病小鼠,分为5组。一组作为对照,另一组作为标准,另一组分别作为正己烷,乙酸乙酯和甲醇提取物的测试组。小鼠感染了伯氏疟原虫的氯喹敏感株,并放置72小时以建立感染。确定600 mgkg-1 bw day-1剂量是安全的,并用于分析。感染72小时后,从D3至D7每天一次皮下施用植物提取物,持续4天。对照组给予0.9w / v生理盐水。检查了来自尾巴血液的浓稠和稀薄的血液涂片是否有寄生虫。将5mg / kg体重的氯喹磷酸酯用作对照药物,给予阳性对照。结果:埃及双歧杆菌的三个馏分(己烷,乙酸乙酯和甲醇提取物)都不能完全清除循环中的寄生虫。实际上,给予埃及双歧杆菌甲醇提取物的小鼠组在对照组之前死亡,而给予乙酸乙酯和己烷组分的两组均在感染后第14天死亡。给予己烷和乙酸乙酯提取物的小鼠分别在第6天和第10天抑制了寄生虫血症,这表明纯化和分离这些粗提取物以了解负责降低寄生虫血症的活性化合物可以用作治疗目标。疟疾,结论:埃及双歧杆菌的茎提取物对疟原虫具有抑制作用,但无疗效。进一步的纯化和分离活性化合物可以帮助发现一种新的抗疟药。因此可以认为,埃及除虫杆菌通过除杀线虫作用外的其他机制可用于草药疟疾的治疗。组织学研究可以确定在对照组之前用甲醇提取物治疗的组死亡的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号